Avience Biomedicals Ltd vs Prevest Denpro Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 26, 2026

Key Highlights

The Latest Trading Price of Avience Biomedicals Ltd is ₹ 240 as of 26 Oct 10:47 . The P/E Ratio of Avience Biomedicals Ltd is 0 as of March 2024 .The P/E Ratio of Prevest Denpro Ltd is 26.3 as of March 2024 . The Market Cap of Avience Biomedicals Ltd is ₹ 0 crore as of March 2024 .The Market Cap of Prevest Denpro Ltd is ₹ 423.77 crore as of March 2024 . The revenue of Avience Biomedicals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Prevest Denpro Ltd for the Jun '26 is ₹ 20.38 crore as compare to the Mar '26 revenue of ₹ 20.35 crore. This represent the growth of 0.15% The ebitda of Avience Biomedicals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Prevest Denpro Ltd for the Jun '26 is ₹ 8.08 crore as compare to the Mar '26 ebitda of ₹ 8.32 crore. This represent the decline of -2.88% The net profit of Avience Biomedicals Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The net profit of Prevest Denpro Ltd changed from ₹ 3.67 crore to ₹ 5.64 crore over 9 quarters. This represents a CAGR of 21.04% The Dividend Payout of Avience Biomedicals Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Prevest Denpro Ltd changed from 7.64 % on March 2023 to 5.6 % on March 2026 . This represents a CAGR of -7.47% over 4 years .

About Avience Biomedicals Ltd

Avience Biomedicals Limited was originally incorporated as Private Limited Company as 'Avience Biomedicals Private Limited' on December 23, 2019 with the Registrar of Companies, Delhi.
Later, Company's status got converted into a Public Limited Company, the name of the Company was changed to 'Avience Biomedicals Limited' and fresh Certificate of incorporation dated September 3, 2024, was issued by the Registrar of Companies, Delhi. Avience Biomedicals Limited is a medical consumable company dedicated to manufacturing of Vitro-Diagnostic (IVD) products and medical devices in Noida, Uttar Pradesh, India.
In vitro diagnostics (IVDs) are tests that can detect disease, conditions and infections. The Company commenced its journey by producing essential diagnostic kits like Viral Transport Media (VTM), Covid, Human Immunodeficiency Viruses (HIV), HBs AG, Malaria, Dengue and others aimed at aiding medical institutions with affordable and good-quality solutions.

About Prevest Denpro Ltd

Prevest Denpro Limited is one of the world's leading dental materials manufacturer, which was incorporated on May 05, 1999, with the Registrar of Companies, Jammu & Kashmir.
The Company is primarily involved in the manufacturing of Dental Preparations. The Company develop, manufacture and market a comprehensive portfolio of dental materials for diagnosing, treating and preventing dental conditions as well as improving the aesthetics of the human smile.
The product offerings addresses majority of dentists' clinical needs for consumable dental materials.
The product portfolio covers a wide spectrum of materials for endodontics, prosthodontics, orthodontics, periodontics, restorative dentistry, aesthetic dentistry and laboratory consumables.
The products are sold in over 75 countries in the regions of Europe, Asia, South America, Middle East and Africa.

FAQs for the comparison of Avience Biomedicals Ltd and Prevest Denpro Ltd

Which company has a larger market capitalization, Avience Biomedicals Ltd or Prevest Denpro Ltd?

Market cap of Avience Biomedicals Ltd is 131 Cr while Market cap of Prevest Denpro Ltd is 453 Cr

What are the key factors driving the stock performance of Avience Biomedicals Ltd and Prevest Denpro Ltd?

The stock performance of Avience Biomedicals Ltd and Prevest Denpro Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Avience Biomedicals Ltd and Prevest Denpro Ltd?

As of October 26, 2026, the Avience Biomedicals Ltd stock price is INR ₹240.0. On the other hand, Prevest Denpro Ltd stock price is INR ₹377.55.

How do dividend payouts of Avience Biomedicals Ltd and Prevest Denpro Ltd compare?

To compare the dividend payouts of Avience Biomedicals Ltd and Prevest Denpro Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.